Innophos (NASDAQ:IPHS)
has come back strong from an awful 2015, with the shares up more than
90% over the last year after a nearly 50% drop in 2015 brought about by a
run of weak performance tied to iffy demand and more import
competition. New management is targeting common-sense drivers for
internal self-improvement, but the company's end markets remain soft and
pricing is still weak. While I do think there is room for meaningful
margin improvement from here, it's hard not to see today's price as an
ample reflection of those expected improvements.
Read more here:
Self-Improvement Not Quite Enough For Innophos
No comments:
Post a Comment